Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma
Crossref DOI link: https://doi.org/10.1007/s00280-015-2873-x
Published Online: 2015-09-26
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yamazaki, N.
Kiyohara, Y.
Uhara, H.
Fukushima, S.
Uchi, H.
Shibagaki, N.
Tsutsumida, A.
Yoshikawa, S.
Okuyama, R.
Ito, Y.
Tokudome, T.
License valid from 2015-09-26